期刊文献+

Foxp3,Galectin-9,PD-L1在小鼠DC2.4细胞的表达 被引量:1

Expression of Foxp3,Galectin-9 and PD-L1 in mouse DC2.4 cell line
下载PDF
导出
摘要 目的观察CD80,CD86,Foxp3,Galectin-9,PD-L1在小鼠DC细胞的表达,了解小鼠DC2.4细胞系的免疫学特性。方法用含10%胎牛血清的RPMI-1640培养液培养小鼠DC2.4细胞,光学显微镜观察细胞形态;流式细胞术检测CD80,CD86,Foxp3,Galectin-9,PD-L1在DC2.4细胞表达。结果光学显微镜示小鼠DC2.4细胞贴壁生长,呈树突、梭形及不规则形;流式细胞术检测DC2.4细胞CD80表达为91.04%±4.90%,CD86表达为98.54%±1.96%,Foxp3无或微表达,Galectin-9表达为14.33%±2.94%,PD-L1表达为98.80%±0.63%。结论小鼠DC2.4细胞是一个高表达CD80,CD86及PD-L1,低表达Galectin-9,无或微表达Foxp3的细胞系。 Objective To observe the expression of CD80,CD86,Foxp3,Galectin-9 and PD-L1 in mouse dendritic cells(DC) and to study the immunological characteristic of mouse DC2.4 cell line.Methods Morphology of mouse DC2.4 cells was observed under an optical microscope after the cells were cultured with RPMI-1640 culture medium containing 10% fetal calf serum(FCS).Expressions of Foxp3,Galectin-9 and PD-L1 in DC cells were detected by flow cytometry(FCM).Results Optical microscopy revealed that the DC2.4 cells grew along the wall of DC and were dendritic,spindle,and irregular in shape.Flow cytometry showed that 91.04%±4.90% of CD80 and 98.54%±1.96% of CD86 were expressed in DC2.4 cells,respectively.Foxp3 was not or seldom expressed,while 14.33%±2.94% of Galectin-9 and 98.80%±0.63% of PD-L1 were expressed,respectively,in DC2.4 cells.Conclusion CD80,CD86 and PD-L1 are highly expressed,Galectin-9 is slowly expressed,and Foxp3 is not or seldom expressed in DC2.4 cell line.
出处 《军医进修学院学报》 CAS 2011年第1期75-77,共3页 Academic Journal of Pla Postgraduate Medical School
基金 国家自然科学基金项目(30973245) 中国博士后科学基金项目(20100471821)~~
关键词 DC2.4 FOXP3 半乳糖凝集素-9 程序化死亡因子配体1 DC2.4 Foxp3 Galectin-9 PD-L1
  • 相关文献

参考文献14

  • 1Li M, Zhang X, Zheng X, et al. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory ceils in transplant tolerance [ J ] . Int Immunol, 2008, 20 ( 2 ) : 285-293.
  • 2Nouri-Shirazi M, Thomson AW. Dendritic cells as promoters of transplant tolerance [ J ] . Expert Opin Biol Ther, 2006, 6 ( 4 ) : 325-339.
  • 3Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [ J ] . Science, 2003, 299 ( 5609 ) : 1057-1061.
  • 4Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells [ J ] . Nat hnmunol, 2003, 4 (4) : 330-336.
  • 5Chauhan SK, Saban DR, Lee HK, et al. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation [ J ]. J Immunol, 2009, 182 ( 1 ) : 148-153.
  • 6Wang F, He W, Yuan J, et al. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts [ J ] . Transpl Immunol, 2008, 19 ( 1 ) : 12-19.
  • 7张意,吴聪,蒋应明,龙瑶,陈国友.PD-L1-Ig融合蛋白的酵母表达及其对T细胞的抑制作用[J].中国肿瘤生物治疗杂志,2009,16(5):464-468. 被引量:3
  • 8Shen Z, Reznikoff G, Dranoff G, et al. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules [ J ] . J Immunol, 1997, 158 ( 6 ) : 2723-2730.
  • 9Lipscomb MW, Taylor JL, Goldbach CJ, et al. DC expressing transgene Foxp3 are regulatory APC [ J ] . Eur J immunol, 2010, 40 ( 2 ) : 480-493.
  • 10Naka EL, Ponciano VC, Cenedeze MA, et al. Detection of the Tim-3 ligand, galectin-9, inside the allograft during a rejection episode [ J ] . Int Immunopharmacol, 2009, 9 ( 6 ) : 658-662.

二级参考文献31

  • 1罗建飞,陈必成,陈忠华.小鼠骨髓来源树突状细胞和DC2.4形态与功能比较[J].中国康复,2005,20(3):145-146. 被引量:9
  • 2顾春瑜,王前,郑磊,裘宇容.小鼠骨髓耐受性树突状细胞的体外培养与鉴定[J].第一军医大学学报,2005,25(8):959-962. 被引量:9
  • 3Rosignoli G, Lim CH, Bower M, et al. Programmed death (PD)- 1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1- infected individuals[J]. Clin Exp Immunol, 2009,157 ( 1 ) :90- 97.
  • 4WaismanA, Yogev N. B7-H1 and CD8 ^+ Treg: the enigmatic role of B7-H1 in peripheral tolerance [ J]. Eur J Imnmnol, 2009, 39 (6) : 1448-1451.
  • 5Rilev JL. PD-1 signaling in primary T cells [J]. Immunol Rev, 2009, 229(1) : 114-125.
  • 6Brown JA, Dorfman DM, Ma FR, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production [J]. J Immunol, 2005, 175 (3) : 1257- 1266.
  • 7Zhang L, Gajewski TF, Kline J, et al. PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leu- kemia model [J]. Blood, 2009, 114(8) : 1545-1552.
  • 8Parekh VV, Lalani S, Kim S, et al. PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells [ J]. J Immunol, 2009, 182(5) : 2816-2826.
  • 9Wu YF, Wan T, Zhou XY, et al. HSP70-1ike protein 1 fusion protein enhance induction of carcinoembryonic antigen-specific CD8 ^+ CTL response by dentritic cell vaccine [J]. Cancer Res, 2005, 65( 11 ) : 4947-4954.
  • 10Franceschini D, Paroli M, Francavilla V, et al. PD-LI negatively regulates CD4 ^+CD25^+ Foxp3 ^+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV [ J]. J Clin Invest, 2009, 119(3) : 551-564.

共引文献5

同被引文献33

  • 1Niederkorn JY. Corneal transplantation and immune privilege[J].{H}International Reviews of Immunology,2013,(01):57-67.
  • 2Al-Mohaimeed MM. Penetrating keratoplasty for keratoconus:visual and graft survival outcomes[J].Int J Health Sci(Qassim),2013,(01):67-74.
  • 3Cassidy D,Beltz J,Jhanji V. Recent advances in corneal transplantation for keratoconus[J].Clin Exp Optom,2013,(02):165-172.
  • 4Sathe P,Shortman K. The steady-state development of splenic dendritic cells[J].Mucosal Immunol,2008,(06):425-431.
  • 5Shortman K,Naik SH. Steady-state and inflammatory dendritic-cell development[J].{H}Nature reviews Immunology,2007,(01):19-30.
  • 6Ueno H,Klechevsky E,Morita R. Dendritic cell subsets in health and disease[J].{H}Immunological Reviews,2007.118-142.
  • 7Wu L,Liu YJ. Development of dendritic-cell lineages[J].{H}IMMUNITY,2007,(06):741-750.
  • 8Colvin BL,Matta BM,Thomson AW. Dendritic cells and chemokine-directed migration in transplantation:where are we headed[J].{H}CLINICS IN LABORATORY MEDICINE,2008,(03):375-384.
  • 9Forrester JV,Xu H,Kuffová L. Dendritic cell physiology and function in the eye[J].{H}Immunological Reviews,2010,(01):282-304.
  • 10Boisgérault F,Liu Y,Anosova N. Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants[J].{H}TRANSPLANTATION,2009,(01):16-23.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部